What We Work On
We advise radiopharmaceutical, biotech, and CDMO organizations during critical development, commercialization, and manufacturing transitions.
Our work focuses on ensuring technically sound programs can execute successfully in real operating environments — from planning through clinical and early commercial production.
We’re most often engaged when operational execution is unclear, at risk, or becoming difficult to manage.
Commercialization and Launch Planning
As programs approach clinical and early commercial stages, operational planning becomes as critical as development.
We help teams align manufacturing strategy, capacity planning, and execution with real-world operational constraints to ensure launch readiness.
Tech Transfer and Manufacturing Readiness
Transitioning from R&D into GMP manufacturing introduces complexity many teams underestimate.
We help coordinate facility readiness, documentation, and workflows so programs can enter clinical production without preventable delays.
Program and Development Strategy
Strong science alone is not enough. Programs require a clear operational pathway.
We help define development sequencing, identify manufacturing and CMC risks early, and align technical work with realistic execution timelines.
CDMO and Supply Chain Strategy
External manufacturing partnerships often determine program success.
We support CDMO selection, scope definition, and vendor coordination to ensure partnerships are structured realistically and programs avoid common execution pitfalls.